316 related articles for article (PubMed ID: 1973322)
1. Long-term evaluation following resection of apparently benign pheochromocytoma(s)/paraganglioma(s).
van Heerden JA; Roland CF; Carney JA; Sheps SG; Grant CS
World J Surg; 1990; 14(3):325-9. PubMed ID: 1973322
[TBL] [Abstract][Full Text] [Related]
2. Endoscopic treatment of solitary, bilateral, multiple, and recurrent pheochromocytomas and paragangliomas.
Walz MK; Peitgen K; Neumann HP; Janssen OE; Philipp T; Mann K
World J Surg; 2002 Aug; 26(8):1005-12. PubMed ID: 12045858
[TBL] [Abstract][Full Text] [Related]
3. Laparoscopic surgery for pheochromocytoma: adrenalectomy, partial resection, excision of paragangliomas.
Janetschek G; Finkenstedt G; Gasser R; Waibel UG; Peschel R; Bartsch G; Neumann HP
J Urol; 1998 Aug; 160(2):330-4. PubMed ID: 9679871
[TBL] [Abstract][Full Text] [Related]
4. Outcomes of pheochromocytoma management in the laparoscopic era.
Solorzano CC; Lew JI; Wilhelm SM; Sumner W; Huang W; Wu W; Montano R; Sleeman D; Prinz RA
Ann Surg Oncol; 2007 Oct; 14(10):3004-10. PubMed ID: 17690941
[TBL] [Abstract][Full Text] [Related]
5. Perioperative outcomes of syndromic paraganglioma and pheochromocytoma resection in patients with von Hippel-Lindau disease, multiple endocrine neoplasia type 2, or neurofibromatosis type 1.
Butz JJ; Yan Q; McKenzie TJ; Weingarten TN; Cavalcante AN; Bancos I; Young WF; Schroeder DR; Martin DP; Sprung J
Surgery; 2017 Dec; 162(6):1259-1269. PubMed ID: 28919049
[TBL] [Abstract][Full Text] [Related]
6. Surgical management of hereditary pheochromocytoma.
Yip L; Lee JE; Shapiro SE; Waguespack SG; Sherman SI; Hoff AO; Gagel RF; Arens JF; Evans DB
J Am Coll Surg; 2004 Apr; 198(4):525-34; discussion 534-5. PubMed ID: 15051000
[TBL] [Abstract][Full Text] [Related]
7. Clinical spectrum and outcome of functional extraadrenal paraganglioma.
O'Riordain DS; Young WF; Grant CS; Carney JA; van Heerden JA
World J Surg; 1996 Sep; 20(7):916-21; discussion 922. PubMed ID: 8678971
[TBL] [Abstract][Full Text] [Related]
8. MANAGEMENT OF ENDOCRINE DISEASE: Recurrence or new tumors after complete resection of pheochromocytomas and paragangliomas: a systematic review and meta-analysis.
Amar L; Lussey-Lepoutre C; Lenders JW; Djadi-Prat J; Plouin PF; Steichen O
Eur J Endocrinol; 2016 Oct; 175(4):R135-45. PubMed ID: 27080352
[TBL] [Abstract][Full Text] [Related]
9. [Can pheochromocytoma be considered a benign unilateral intra-adrenal sporadic hypertensive tumor ? Reflections on a series of 105 surgically treated subdiaphragmatic chromaffin tumors].
Proye C; Vix M; Goropoulos A; Carnaille B; Vermesse B; Kerlo P; Lecomte-Houcke M
Chirurgie; 1992; 118(8):433-8. PubMed ID: 1343986
[TBL] [Abstract][Full Text] [Related]
10. Pheochromocytoma and paraganglioma in children: a review of medical and surgical management at a tertiary care center.
Pham TH; Moir C; Thompson GB; Zarroug AE; Hamner CE; Farley D; van Heerden J; Lteif AN; Young WF
Pediatrics; 2006 Sep; 118(3):1109-17. PubMed ID: 16951005
[TBL] [Abstract][Full Text] [Related]
11. Management of pheochromocytomas in patients with multiple endocrine neoplasia type 2 syndromes.
Lairmore TC; Ball DW; Baylin SB; Wells SA
Ann Surg; 1993 Jun; 217(6):595-601; discussion 601-3. PubMed ID: 8099474
[TBL] [Abstract][Full Text] [Related]
12. Perianesthetic risks and outcomes of pheochromocytoma and paraganglioma resection.
Kinney MA; Warner ME; vanHeerden JA; Horlocker TT; Young WF; Schroeder DR; Maxson PM; Warner MA
Anesth Analg; 2000 Nov; 91(5):1118-23. PubMed ID: 11049893
[TBL] [Abstract][Full Text] [Related]
13. Clinical experience over 48 years with pheochromocytoma.
Goldstein RE; O'Neill JA; Holcomb GW; Morgan WM; Neblett WW; Oates JA; Brown N; Nadeau J; Smith B; Page DL; Abumrad NN; Scott HW
Ann Surg; 1999 Jun; 229(6):755-64; discussion 764-6. PubMed ID: 10363888
[TBL] [Abstract][Full Text] [Related]
14. [Modern aspects of management of pheochromocytoma and abdominopelvic paraganglioma].
Proye C
Ann Chir; 1998; 52(7):643-56. PubMed ID: 9805803
[No Abstract] [Full Text] [Related]
15. Long-term postoperative follow-up in patients with apparently benign pheochromocytoma and paraganglioma.
Amar L; Fassnacht M; Gimenez-Roqueplo AP; Januszewicz A; Prejbisz A; Timmers H; Plouin PF
Horm Metab Res; 2012 May; 44(5):385-9. PubMed ID: 22351478
[TBL] [Abstract][Full Text] [Related]
16. [Diagnosis of and surgical therapy for pheochromocytoma and paraganglioma].
Musholt TJ
Zentralbl Chir; 2010 Jun; 135(3):226-32. PubMed ID: 20549585
[TBL] [Abstract][Full Text] [Related]
17. Questionability of the benefits of routine laparotomy as the surgical approach for pheochromocytomas and abdominal paragangliomas.
Pattou FN; Combemale FP; Poirette JF; Carnaille B; Wemeau JL; Huglo D; Ernst O; Proye CA
Surgery; 1996 Dec; 120(6):1006-11; discussion 1012. PubMed ID: 8957487
[TBL] [Abstract][Full Text] [Related]
18. Pheochromocytomas and paragangliomas in von Hippel-Lindau disease: a role for laparoscopic and cortical-sparing surgery.
Baghai M; Thompson GB; Young WF; Grant CS; Michels VV; van Heerden JA
Arch Surg; 2002 Jun; 137(6):682-8; discussion 688-9. PubMed ID: 12049539
[TBL] [Abstract][Full Text] [Related]
19. Estimated risk of pheochromocytoma recurrence after adrenal-sparing surgery in patients with multiple endocrine neoplasia type 2A.
Asari R; Scheuba C; Kaczirek K; Niederle B
Arch Surg; 2006 Dec; 141(12):1199-205; discussion 1205. PubMed ID: 17178962
[TBL] [Abstract][Full Text] [Related]
20. Update on Pheochromocytoma and Paraganglioma from the SSO Endocrine and Head and Neck Disease Site Working Group, Part 2 of 2: Perioperative Management and Outcomes of Pheochromocytoma and Paraganglioma.
Patel D; Phay JE; Yen TWF; Dickson PV; Wang TS; Garcia R; Yang AD; Kim LT; Solórzano CC
Ann Surg Oncol; 2020 May; 27(5):1338-1347. PubMed ID: 32112213
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
